1 – 17 of 17
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes
2024) In Cardiovascular Revascularization Medicine(
- Contribution to journal › Article
- 2023
-
Mark
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
(
- Contribution to journal › Article
- 2019
-
Mark
Mean wall thickness improves characterization and prognosis in left ventricular hypertrophy
2019) Society for Cardiovascular Magnetic Resonance: 22nd Annual Scientific Sessions(
- Contribution to conference › Poster
-
Mark
Left ventricular global wall thickness is easily calculated, detects and characterizes hypertrophy, and has prognostic utility
2019) 20th Cardiovascular Spring Meeting(
- Contribution to conference › Abstract
- 2018
-
Mark
Response by Jablonowski et al to Letter Regarding Article, "Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone : Comparison of Four Analysis Methods"
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
A simplified left ventricular end-diastolic mean wall thickness-to-volume ratio estimated from left ventricular mass and end-diastolic volume distinguishes physiological from pathological hypertrophy
2017) Society for Cardiovascular Magnetic Resonance: 20th Annual Scientific Sessions(
- Contribution to conference › Poster
-
Mark
Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in ischemic and nonischemic cardiomyopathy patients using late gadolinium enhancement border zone comparison of four analysis methods
(
- Contribution to journal › Article
- 2016
-
Mark
The Authors Reply
(
- Contribution to journal › Letter
- 2015
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
Contrast-Enhanced CMR Overestimates Early Myocardial Infarct Size: Mechanistic Insights Using ECV Measurements on Day 1 and Day 7.
(
- Contribution to journal › Article
- 2013
-
Mark
Genetic Associations with Valvular Calcification and Aortic Stenosis
(
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
(
- Contribution to journal › Letter
-
Mark
Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: comparison to myocardial perfusion single photon emission computed tomography.
(
- Contribution to journal › Article
- 2012
-
Mark
Quantification of myocardium at risk in myocardial perfusion SPECT by co-registration and fusion with delayed contrast-enhanced magnetic resonance imaging - an experimental ex vivo study.
(
- Contribution to journal › Article
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
(
- Contribution to journal › Article
-
Mark
Plasma Levels of Liver-Specific miR-122 is Massively Increased in a Porcine Cardiogenic Shock Model and Attenuated by Hypothermia.
(
- Contribution to journal › Article
- 2010
-
Mark
Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model
(
- Contribution to journal › Article